Keeley Teton Advisors, LLC Supernus Pharmaceuticals, Inc. Transaction History
Keeley Teton Advisors, LLC
- $756 Million
- Q2 2024
A detailed history of Keeley Teton Advisors, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Keeley Teton Advisors, LLC holds 15,800 shares of SUPN stock, worth $539,570. This represents 0.06% of its overall portfolio holdings.
Number of Shares
15,800
Previous 15,800
-0.0%
Holding current value
$539,570
Previous $538,000
21.56%
% of portfolio
0.06%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding SUPN
# of Institutions
259Shares Held
59.3MCall Options Held
47.9KPut Options Held
13.1K-
Black Rock Inc. New York, NY10.4MShares$355 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.14MShares$210 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.27MShares$180 Million1.83% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.87MShares$97.9 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.68MShares$91.5 Million0.08% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.83B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...